Alain E. Lagarde
Impact in
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
Papers in
-
- Amino Acid Enzymes and Metabolism 5
-
- Cancer Genomics and Diagnostics 3
- Co-authors
- Frances Alice Shepherd (1 shared paper)Frank C. Richardson (1 shared paper)Keyue Ding (1 shared paper)Manijeh Daneshmand (1 shared paper)Paula M. Marrano (1 shared paper)Lesley Seymour (1 shared paper)Geoffrey Liu (1 shared paper)Ian A. J. Lorimer (1 shared paper)
In The Last Decade
Alain E. Lagarde
21 papers receiving 2.0k citations
Alain E. Lagarde's Hit Papers
Peers
Comparison fields: 5 of 96
- Pulmonary and Respiratory Medicine 1.2k
- Oncology 935
- Cancer Research 372
- Pathology and Forensic Medicine 183
- Molecular Biology 660
Countries citing papers authored by Alain E. Lagarde
This map shows the geographic impact of Alain E. Lagarde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain E. Lagarde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain E. Lagarde more than expected).
Fields of papers citing papers by Alain E. Lagarde
This network shows the impact of papers produced by Alain E. Lagarde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain E. Lagarde. The network helps show where Alain E. Lagarde may publish in the future.
Co-authors
The 25 scholars most cited alongside Alain E. Lagarde, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome Hit paper breakdown → | 2005 | 1605 |
| 2 | 2004 | 104 | |
| 3 | 2005 | 89 | |
| 4 | 2003 | 84 | |
| 5 | 1983 | 44 | |
| 6 | 2001 | 37 | |
| 7 | 1988 | 36 | |
| 8 | 1973 | 26 | |
| 9 | 1973 | 23 | |
| 10 | 1974 | 21 | |
| 11 | 1986 | 21 | |
| 12 | 1984 | 20 | |
| 13 | 1976 | 16 | |
| 14 | 1974 | 12 | |
| 15 | 1979 | 12 | |
| 16 | 1989 | 10 | |
| 17 | 1975 | 9 | |
| 18 | 1984 | 8 | |
| 19 | 1986 | 6 | |
| 20 | 1977 | 2 |
About Alain E. Lagarde
Alain E. Lagarde is a scholar working on Biochemistry, Cancer Research, Molecular Biology, Pharmaceutical Science and Cell Biology, having authored 22 papers that have together received 2.2k indexed citations. Recurring topics across this work include Amino Acid Enzymes and Metabolism (5 papers), Cancer Genomics and Diagnostics (3 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers), Polyamine Metabolism and Applications (3 papers), Chemical Reactions and Isotopes (2 papers), Biochemical and Molecular Research (2 papers), Genomic variations and chromosomal abnormalities (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.2k citations), Oncology (935 citations), Cancer Research (372 citations), Pathology and Forensic Medicine (183 citations) and Molecular Biology (660 citations). Alain E. Lagarde has collaborated with scholars based in Canada, France and India. Frequent co-authors include Frances Alice Shepherd, Frank C. Richardson, Keyue Ding, Manijeh Daneshmand, Paula M. Marrano, Lesley Seymour, Geoffrey Liu, Ian A. J. Lorimer, Chang‐Qi Zhu and Suzanne Kamel‐Reid. Their work appears in journals such as European Journal of Biochemistry, International Journal of Cancer, Gastroenterology, Journal of Cellular Physiology and The American Journal of Human Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.